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Recombinase-activating gene-2-deficient (Rag2/) mice lacking
functional lymphocytes provide a useful model of chronic inflam-
matory bowel disease-emulating events in human colon cancer.
Infection of Rag2/ mice with Helicobacter hepaticus led to
accumulation of macrophages and neutrophils in the colon, a
process temporally related to up-regulation of tissue inducible
nitric oxide synthase (iNOS) expression at the site of infection and
increased nitric oxide (NO) production, as evidenced by urinary
excretion of nitrate. Progressive development of increasingly se-
vere inflammation, hyperplasia, dysplasia, and cancer accompa-
nied these changes. Concurrent administration of an iNOS inhibitor
prevented NO production and abrogated epithelial pathology and
inhibited the onset of cancer. The presence of Gr-1 neutrophils
and elevated tumor necrosis factor- (TNF-) expression in colon
were required for increased iNOS expression and cancer, whereas
interleukin-10 (IL-10) down-regulated TNF- and iNOS expression
and suppressed cancer. Anti-inflammatory CD4 regulatory lym-
phocytes also down-regulated iNOS and reduced cancer formation.
Collectively, these results confirm essential roles for inflammation,
increased TNF- expression, and elevated NO production in colon
carcinogenesis.
colorectal cancer  IBD  innate immunity
Chronic Helicobacter pylori infection in humans leads togastritis and has been established as a causative agent for
human gastric cancer (1). Inflammatory bowel diseases (IBDs),
such as Crohn’s disease and ulcerative colitis, also increase risk
for colon cancer (2, 3). Generation of nitric oxide (NO) by
inducible NO synthase (iNOS) is a central feature of chronic
inflammatory diseases in the gastrointestinal tract (4–9), but
precise mechanistic roles for NO in colon cancer development
remain undefined.
Colon cancer patients exhibit evidence of nitrosative and
oxidative stresses that increase cancer risk (10), resulting from
mutagenic reactive oxygen and nitrogen species derived from
NO generated by immune cells (6, 11–15). Roles for chronic
bacterial infection in IBD and colon cancer have been identified
recently in recombinase-activating gene-2-deficient mice
(Rag2/), which completely lack functional lymphocytes (16–
18). We have exploited this mouse model of chronic IBD-
associated cancer for studies of the role of NO and its products
because it emulates naturally occurring inflammatory events in
humans (16, 19, 20).
Rag2/ mice have been used to assess functions of lympho-
cytes by adoptive transfer. Populations of CD4 T cells with low
or high expression of CD45RB (17, 21, 22) or CD25 (16, 18, 23,
24) prevent or accelerate colitis in these animals. In wild-type
(wt) mice, protection against inflammatory pathology induced
by bacterial infection has been attributed to interleukin-10
(IL-10) and IL-10-dependent functions of CD4 cells (18, 20, 25,
26). Collectively, this evidence forms the rationale for the
hypothesis that NO overproduction comprises a linkage between
Helicobacter hepaticus-induced inflammation and induction of
colon cancer (16), which we further test in this study by assessing
protective effects of N-methyl-arginine (NMA), an iNOS inhib-
itor, administered in the drinking water of infected animals. All
experiments were carried out in Rag2/ mice unless otherwise
stated.
Results
Infection and NO Production. To assess the contribution of NO
production to colon cancer development, Rag2/ and wt mice
were infected with H. hepaticus (16, 18). Total NO production
wasmeasured by urinary nitrate (NO3) excretion (11). Infected,
but not uninfected, mice showed a time-dependent increase (P
0.05) in urinary NO3 excretion beginning 2 weeks after infec-
tion (Fig. 1A), which was temporally associated with develop-
ment of IBD and carcinoma (Table 1). In contrast, infected wt
mice, showed no elevation of urinary nitrate and did not develop
cancer (Fig. 1B) (16), indicating that infection alone was not
sufficient to induce cancer.
To estimate levels of NO synthesis at the site of infection (20),
iNOS expression was examined by quantitative RT-PCR on sec-
tions of ascending colon. Tissue from infected mice contained
200-fold higher (P  0.001) levels of iNOS mRNA than were
present in uninfected Rag2/ or wt controls (Fig. 2A). Expression
of iNOS protein in situ in ascending colon was localized by FIHC
to epithelial cells and macrophages, and less frequently to granu-
locytes [Fig. 1 C and D and supporting information (SI) Fig. S1].
Induction of iNOS was associated with the presence of 7/4
polymorphonuclear cells (Table S1) (18, 20, 27), and also correlated
with up-regulation of tumor necrosis factor- (TNF-), IL-6, and
MIP-2 (Fig. 2A) (28). The iNOS-dependent activities of bone
marrow-derived 7/4 neutrophils have been shown previously to be
required for induction of IBD in mice (29).
Immune Cell Modulation of Infection-Induced NO Production and
Colon Pathology.Myeloid differentiation antigen Gr-1 (or Ly-6G)
is expressed on bone marrow precursors and peripheral neutro-
phils and is considered a good marker for these populations.
Treatment with anti-Gr-1 antibody has been shown previously to
deplete mature neutrophils and abrogate Helicobacter-induced
gastritis in mice (30). For further assessment of the role of
neutrophils in colon carcinogenesis in infected Rag2/mice, we
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performed depletion experiments by intraperitoneal injection of
anti-Gr-1 antibody thrice weekly for 10 days beginning at 6 weeks
after infection. Depletion of Gr-1 cells significantly (P  0.01)
decreased iNOS gene expression levels (Fig. 2B) and the severity
of colon pathology (Table S1) in infected mice compared with
infected, sham IgG-treated animals. Interestingly, depletion of
Gr1 cells eliminated 7/4 neutrophils (  0.4  0.22 cells in
treated vs. 28.4  3.33 cells in control mice) and significantly
decreased macrophages (6.6  1.88 cells in treated vs. 13.8 
1.14 cells in control mice). iNOS expression within epithelia
and other inflammatory cells in the colon also was suppressed
(Fig. S1 B and D) compared with sham-treated infected mice
(Fig. S1 A and C). Depletion also decreased colon mRNA levels
of TNF- (P  0.001) and IL-6 (P  0.05) (Fig. 2B), suggesting
that Gr-1 cells may induce iNOS expression through cytokine-
mediated processes. Similarly, their depletion decreased the
frequency of myeloperoxidase (MPO)-positive cells (21.3  4.3
vs. 4.0  1.3 MPO cells per 40 field in sham and anti-Gr-1
mice, respectively; P  0.01) in the colon (Fig. S1). Taken
together, these results demonstrate that Gr-1 cells are required
for colitis-associated cancer in H. hepaticus-infected Rag2/
mice, and suggest a functional relationship between iNOS and
MPO in the carcinogenesis process (31).
Because nuclear factor B (NF-B)-mediated inflammatory
signaling is dependent upon TNF- (32), we postulated that this
proinflammatory cytokine would be required for recruitment
and activation of Gr-1 neutrophils. We therefore neutralized
TNF- in Rag2/mice by injection of anti-TNF antibody, which
significantly (P 0.05) decreased expression of IL-6, MIP-2, and
iNOS (Fig. 2C) and reduced bowel pathology (Table S1) com-
pared with uninfected controls. These results suggest a sequence
of events in which bacterial infection triggers increased TNF-
expression, leading to up-regulation of iNOS and contributing to
development of colon cancer in infected mice.
Anti-inflammatory activities of IL-10 have been shown to
inhibit TNF--dependent responses to pathogenic bacteria in
several mouse models (18, 20, 25). We therefore used Rag2/-
deficient mice also lacking IL-10 (IL10/Rag2/) to determine
whether IL-10 was capable of preventing iNOS up-regulation
triggered by infection. Infected double-knockout mice showed
significant (P  0.01) increases in iNOS gene expression (Fig.
2D), 7/4 neutrophils, and F4/80 macrophages (Table S2), as
well as inflammatory pathology (Fig. S2 C–E) and colon tumors
(P  0.05; Table 1), when compared with infected Rag2/
control mice. Uninfected IL10/Rag2/ mice had undetect-
ably low levels of inflammatory cytokines (Fig. 2D) and colon
pathology (Table 1). Replacement of IL-10 by injection of
IL10-Ig fusion protein restored iNOS and inflammatory cyto-
kine expression to baseline levels (Fig. 2D). Likewise, infected
Rag2/ mice treated with IL10-Ig fusion protein had signifi-
cantly (P  0.05) decreased inflammation and tumor develop-
ment when compared with sham-treated animals (Table 1).
Thus, IL-10 suppressed infection-induced iNOS elevation and
tumor formation, whereas IL10-deficient mice were highly sus-
ceptible to H. hepaticus-induced bowel disease (Table 1 and
Table S2).
To study further the role of IL-10 in modulating infection-
induced responses, we performed adoptive transfer of purified
IL10-producing CD4 lymphocytes into infected Rag2/ mice.
We found that CD4 cells collected from wt but not IL10/
donor mice prevented up-regulation of iNOS (Fig. 2E) and
development of cancer (Table 1). To determine whether regu-
latory T (TREG) cells—i.e., the subset of wt CD4 cells with low
expression of CD45RB that have potent anti-inflammatory
properties (16, 18)—would down-regulate TNF- (18, 27), we
performed adoptive i.v. transfer of 3.0 105 TREG cells into mice
at the time of infection. Mice receiving wt TREG cells had
reduced (P 0.005) epithelial dysplasia in the cecum (Table S3)
and colon, as well as decreased inflammatory gene expression
(Fig. 2E) 3–4 months after infection. However, this inhibitory
effect was not a property of all CD4 cells. Indeed, infected mice
that received the CD4CD45RBhi (TEFF) subset of cells devel-
oped more severe IBD and mucinous carcinoma (Fig. S2 and
Table 1), a variant of colorectal cancer in humans that arises in
about 20% of patients with IBD (33). TEFF cell recipients also
had increased levels of IFN (IFN-) and iNOS (Fig. 2E),
increased urinary NO3 (Fig. 1B), and a higher frequency of
iNOS-bearing F4/80 and MPO cells (data not shown), com-
pared with infected controls. In contrast, uninfected recipients
showed minimal pathology (Table 1), in agreement with the
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Fig. 1. Urinary nitrate excretion after infection with H. hepaticus. (A)
Temporal increase in urinary nitrate excretion followed infection with H.
hepaticus. (B) Nitrate excretion was elevated in infected Rag2/ mice with
cancer but not WT mice without cancer. Treatment with NMA or TREG cells
decreased urinary nitrate levels to that of uninfected Rag2/ mice and
prevented cancer development in infected Rag2/ mice. (C) FIHC showed
colocalization of F4/80 and iNOS proteins in the colon of an H. hepaticus-
infected mouse. (Original magnification, 100.) (D) Higher magnification
(1,000) of C reveals iNOS expression in inflammatory cells.
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previously published findings of others (18). Together, these
data indicate that protective properties of IL10-competent lym-
phocytes reside in the CD45RBlo subset of CD4 cells. Cotrans-
fer of anti-inflammatory TREG cells along with TEFF cells in
infectedmice was sufficient to down-regulate urinary NO3 (Fig.
1B) and colon pathology (Table 1), indicating that IL10-
competent TREG cells inhibited TNF--mediated inflammatory
events leading to cancer.
Suppression of NO Production and Colon Pathology. To confirm the
role of NO in the induction of colon cancer, mice were admin-
istered the iNOS inhibitor NMA in their drinking water contin-
uously, beginning before infection. This treatment resulted in
significantly decreased epithelial hyperplasia in colonic (Fig. 3B)
and cecal (data not shown) epithelia compared with infected
control animals. Decreased epithelial dysplasia was also evident
in treated mice at 3–4 months after infection (Fig. 3B), indicative
of reduced potential for eventual development of malignancy.
Infected animals treated with NMA showed no elevation of
NO3 excretion compared with controls (Fig. 1B), confirming
that NMA inhibited NO production. Levels of innate immune
inflammatory cells (F4/80 macrophages and 7/4 neutrophils)
remained unchanged in infected mice treated with NMA (Fig.
3A), whereas the number of inflammatory cells expressing iNOS
in situ within colonic tissue was reduced by NMA ( 4.2 2.86
cells in NMA-treated vs. 7.2  3.35 cells in sham-treated mice).
This indicated that inhibition of NO formation by NMA, not a
reduction of inflammatory cell counts, was responsible for the
observed diminished pathology. Thus, inhibition of NO produc-
tion in infected mice decreased the probability of colon cancer
development.
Discussion
Observations of Virchow more than a century ago (32) are
supported by many epidemiological studies illustrating that
chronic inflammation increases cancer risks in humans. The
features of colon carcinoma induced in Rag2/ mice by H.
hepaticus infection closely resemble those of colon cancer in
humans (34). Epithelial dysplasia and carcinoma arise in situ
from inflammatory cell foci and epithelial ulceration, then
progress to intramucosal carcinoma, and highly invasive muci-
nous carcinoma (16, 20, 27). Although a bacterial etiology has
not been confirmed for IBD in humans, H. pylori infection has
been shown to lead to gastritis-associated gastric cancer (1).
Treatment of infected mice with NMA reduced epithelial dys-
plasia without having an impact on inflammatory cell levels in
tissues (Fig. 3), in agreement with previous studies (35, 36). Lack
of change in cellular inflammatory cell infiltrates and inflam-
mation in NMA-treated mice (Fig. 3A) points to dysregulation
of NO production rather than the presence of inflammatory cells
per se in the pathogenesis of colon cancer in this system. The host
benefit of blocking NO synthesis beyond IBD-associated colon
cancer is suggested by reduced intestinal adenoma formation in
mice that undergo spontaneous loss of heterozygosity of the
adenomatous polyposis coli (Apc) gene (ApcMin/ mice) using
both inhibitors and mice lacking iNOS (37).
The proinflammatory cytokine TNF- and bacteria-triggered
TNF--dependent increases in inflammatory cell infiltrates and
NO production have been shown to be required for development
of colon cancer in mice (14, 15, 29). Beck et al. (29) revealed the
main source of NO to be bone marrow-derived inflammatory
cells, in particular iNOS-bearing 7/4 granulocytes. Neutrophils
also have been shown to be required for infection-induced cancer
(38, 39). In our experiments, depletion of Gr-1 cells decreased
iNOS expression (Fig. 2B), colitis, and carcinoma (Table 1) and
reduced iNOS expression within epithelial cells and other in-
f lammatory cells (Fig. S1 B and D). It also decreased TNF-
(P  0.001) and IL-6 (P  0.05) (Fig. 2B), suggesting indirect
effects of Gr-1 neutrophils, such as escalating host inflamma-
tory response (28) and oxidative stressors (11, 29, 40), that
promote cancer.
Supplementation with proinflammatory TEFF cells increased
IFN--dependent and TNF--dependent malignancy in inflam-
mation-driven mouse models (41), confirmed by studies showing
increased inflammatory disease after TEFF cell transfer in H.
hepaticus-infected Rag2/ mice (18, 22, 42). Increased IFN-
secretion and NO (11, 15) have been found in humans with
gastrointestinal carcinoma as well (1). Targeting inflammation
and NO is clinically relevant, because mucinous colonic carci-
noma seen in TEFF cell recipient mice most often affects young
humans and has a poor prognosis associated with invasion of
adjacent viscera and lymph nodes beyond the pericolonic region
(33). Cotransfer of CD4 TREG and TEFF cells significantly
protected against colon carcinogenesis (41), and NO was linked
Table 1. Induction of colon pathology in immune-deficient Rag2/ mice by H. hepaticus (Hh) infection and modulating effects
of immune cell augmentation
Hh status Genotype Treatment
Severity of colon pathology*
Carcinoma incidence Neoplastic invasionInflammation Hyperplasia Dysplasia
 wt  0 0 0 0/8
 wt  1 (0–2) 0 (0–1) 0 0/8
 wt  0 (0–1) 0 (0–1) 0 0/8
 Rag2/  0 0 0 0/8
 Rag2/  4 (2–4) 4 (3–4) 3 (0–4)† 7/10 1/10
 Rag2/  3 (2–4) 3 (2–4) 2 (2–3)† 4/10
 Rag2/ wt TEFF 1 (0–2) 0.5 (0–1) 0 0/8 0/10
 Rag2/ wt TEFF 4 (2–4) 4 (1–4) 3 (0–4)† 6/10 4/10
 Rag2/ wt TREG 0 (0–4) 0 (0–3) 0 0/10
 Rag2/ wt TEFF  wt TREG 0 0 0 0/8
 Rag2/ wt CD4 1.5 (1–3) 0 (0–1) 0 (0–1) 0/8
 Rag2/ IL10/ CD4 4 (4–4) 4 (4–4) 3 (3–4)† 8/8 4/8
 Rag2/ IL10-Ig fusion protein 1.5 (0–4) 1 (0–3) 0.5 (0–1) 0/8
 IL10/ Rag2/  1 (0–2) 1 (0–2) 0.5 (0–1) 0/8
 IL10/ Rag2/  4 (4–4) 4 (4–4) 3 (3–4)† 10/10 1/10
 IL10/  3 (3–3) 3 (3–3) 2.5 (2–4)† 4/8 1/10
*Median severity score (range) on 0–4 scale.
†P  0.05 vs. control value by Mann–Whitney U test for nonparametric data
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with increased IL-10-mediated recruitment of protective anti-
inflammatory TREG cells (43). Prior challenge with H. hepaticus
induced IL-10-dependent TREG cells that protected against IBD
in mice (26). TREG cells collected from H. hepaticus-infected
donors had greater potency to protect against intestinal and
mammary cancer than those from uninfected donors (44).
Identifying which TREG subsets are most effective in the regu-
lation of TNF- and NO to prevent or treat infection-associated
colon cancer is a future goal.
Our findings suggest a connection between NO and MPO, an
enzyme present in granulocytes, in which NO is converted to
nitrite, and nitrite is oxidized by MPO to NO2 (31). NO2 is a
strong one-electron oxidant capable of both oxidation and
nitration of nucleic acids, proteins, and lipids (45–49). Products
generated by NO2 oxidation of DNA are toxic and highly
mutagenic (50, 51), and lipid peroxidation products yield reac-
tive carbonyls that also modify DNA to form promutagenic bases
(52). Studies in MPO/ mice showed that formation of nitro-
tyrosine, a product of NO oxidation to peroxynitrite, required
MPO following Klebsiella pneumoniae infection that induced
primarily neutrophil infiltration (53). Only when both nitrite and
MPO were present did nitrotyrosine form.
Our principal findings can be summarized as follows. Infection
of Rag2/ mice with H. hepaticus led to infiltration of macro-
phages and neutrophils into the colon, which was temporally
related to up-regulation of iNOS expression at the site of
infection and increased NO production, evidenced by urinary
excretion of nitrite. Progressive development of increasingly
severe inflammation, hyperplasia, dysplasia, and cancer accom-
panied these changes. Concurrent administration of an iNOS
inhibitor prevented NO production and abrogated the epithelial
Fig. 2. Modulation of expression of iNOS and inflammatory cytokines in colon tissue. (A) Expressions of proinflammatory cytokines and iNOSwere significantly
increased after infectionwithH. hepaticus (Hh).Depletion ofGr-1 cells (B) and TNF- (C) decreased iNOS expression. (D) Infected double-knockoutmice showed
significant increases in iNOS and IFN- gene expression. (E) TEFF cells increased levels of IFN (IFN-) and iNOS expression.
Fig. 3. NO synthase inhibitor NMA inhibits development of malignancy in
mice. (A) Numbers of 7/4 neutrophils and F4/80 macrophages were un-
changed by NMA treatment; therefore, protective effects of NMA were not
attributable to reduced numbers of inflammatory cells. (B) Histopathologic
indices of dysplasia and cancer were reduced by NMA treatment.
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pathology and inhibited the onset of cancer. The presence of
Gr-1 cells and elevated TNF- expression in colon were
required for increased iNOS expression and cancer, whereas
IL-10 down-regulated TNF- and iNOS expression and sup-
pressed cancer. Anti-inflammatory CD4 TREG lymphocytes
down-regulated iNOS and reduced cancer formation. Collec-
tively, these results confirm essential roles for elevated NO
production and TNF- expression in the carcinogenesis process
in this experimental model.
Materials and Methods
Animals. Experiments were conducted in 129/SvEv Rag2/ and wt mice (16)
housed inAssociation for Assessment andAccreditation of Laboratory Animal
Care-approved facilities in static microisolator cages and were approved by
the institutional Animal Care and Use Committee. Each experiment included
6–10mice per group andwas repeated twice (total n 12–20mice per group)
unless otherwise specified. Treatment groups included equal numbers of
males and females unless otherwise specified.
H. hepaticus Infection. Animals were infected with H. hepaticus (strain 3B1,
ATCC 51449) grownand confirmedas pure culture as describedpreviously (16,
54). Mice aged 6–8 weeks received 0.2 mL of fresh inoculum by gavage every
other day for a total of 3 doses. Cecum and colon were collected at necropsy
and analyzed by PCR using H. hepaticus-specific primers to confirm infection
status (16). Subsequent treatments are described below. Time points selected
for tissue harvest were based on typical progression of IBD and dysplasia (16).
For each adoptive transfer experiment (see below), a cohort of age-matched
littermates served as H. hepaticus-infected controls.
Nitrate Excretion. Quantitation of nitrate excretion as a biomarker of endog-
enous NO production was performed as described previously (55). A total of
160 mice in 3 separate experiments were fed a low-nitrate diet (AYN-76A;
Bioserve) for at least 2 weeks before infection to minimize the background
rate of nitrate excretion. Mice were housed individually in metabolic cages,
and urine was collected weekly in 0.5 M NaOH to inhibit bacterial growth.
Total urinary nitrate concentration was determined as described previously
(15, 55).Onehundredmice servedasHelicobacter-free controls. Forty infected
mice were used in the evaluation of NMA effects. At 24 h before infection, 30
mMNMA(EMDChemicals) replaceddrinkingwater for 10mice (2 replications;
total n 20) and equimolar ammonium acetate (Sigma Chemical) for 10mice
(2 replications; total n 20) to serve as sham controls. Mice were euthanized
at 3–4 months after infection
Lymphocyte Transfer. For adoptive transfer of CD4 lymphocytes, 160 mice
(treatment groups of 10 recipient mice, each with 2 replications) underwent
the procedure as described previously (16, 41). Single-cell suspensions of CD4
lymphocytes were prepared as described previously (56, 57) from spleen and
mesenteric lymph nodes from Helicobacter-free wild-type or IL10/ donor
mice backcrossed at least 10 generations onto the 129/SvEv genetic back-
ground. Reanalysis confirmed purity (95%) and phenotype of the cells
before transfer. Rag2/ recipients of wt or IL10/ lymphocytes underwent
adoptive transfer 48 h before infection (16). For replacement of IL-10, murine
IL-10 was fused to IgG2a by using a PCR cloning strategy and cloned into an
adenoviral vector as described previously (27, 57). Serum containing 1 g of
fusion protein was administered by i.p. injection to H. hepaticus-infected
IL10/Rag2/ or Rag2/ mice twice weekly for 6 weeks.
Neutrophil or TNF- Depletion. For experiments involving depletion of Gr-1
cells or neutralization of TNF-, 40 infectedmicewere subdivided into groups
of 10 each, and eachwas dosedwith 0.2mL of anti-Gr-1 or anti-TNF antibody,
or sham isotype IgG control, as described elsewhere (41). Anti-Gr-1 antibody
is widely used to label mature neutrophils. Neutrophils were depleted in 10
infected Rag2/ mice at 6 weeks after infection by i.p. injection of 500
g/mouse Ly-6G antibody (BioExpress) thrice weekly for 10 weeks. Ten mice
infected with H. hepaticus 6 weeks earlier were injected for 10 days with
anti-TNF- antibody (clone XT-3; BioExpress) at 200 mg per mouse thrice
weekly as previously described (44). Mice were euthanized at 3–4 months
after infection, and tissues were evaluated as described below.
IL-10 Modulation. In experiments to determine effects of IL-10 on iNOS ex-
pression, 28 IL10/Rag2/ mice were infected and compared with Rag2/
mice (n  10 with 2 trials; total n  20) as described elsewhere. Additionally,
8 IL10/Rag2/mice were treated by i.p. injection of IL10-Ig fusion protein
to restore IL-10 function. Forty mice served asH. hepaticus-free controls. Mice
were euthanized at 6–8 weeks after infection.
Histopathology. For histologic evaluation, formalin-fixed tissues were embed-
ded in paraffin, cut at 5 m, and stained with hematoxylin and eosin. Lesions
were scored by 2 pathologists blinded to sample identity. Hyperplastic and
inflammatory lesions were graded on a scale of 0 to 4 with ascending severity
as describedpreviously (16, 34).Macrophages andneutrophilswere identified
in intestinal tissue sections with standard avidin-biotin complex immunohis-
tochemistry and were quantified as described previously (41). Immunofluo-
rescence was performed as described elsewhere (58).
Gene Expression. Gene expression analysis was conducted on snap-frozen 0.5-
to 1.0-cm full-thickness sections of ascending colon by TaqMan analysis (Ap-
plied Biosystems) using expression assays designed by Applied Biosystems
(Assays-on-Demand: www.appliedbiosystems.com).
Statistical Analysis. Statistical analyses of colonic lesion scoreswere performed
byusingaMann–WhitneyUnonparametric test for ordinal data. Comparisons
of frequencyof carcinomabetweengroupswereperformedbyusinga2-sided
Fisher exact test. Macrophage and neutrophil counts, urinary nitrates, and
cytokine gene expression were compared by using Student’s t test. Statistical
analyses used Graphpad Prism 4.0 (GraphPad Software, Inc.).
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